Home Clinical Research Syneos Health and Elligo Collaborate to Accelerate Clinical Research to Clinical Care

Syneos Health and Elligo Collaborate to Accelerate Clinical Research to Clinical Care

443
0
Syneos Health and Elligo Collaborate

Leading CRO Syneos Health (Nasdaq: SYNH) and Elligo Health Research (Elligo), a leader in bringing clinical research to clinical care announce a collaboration to mobilize a system of accelerated research to reach real-world patients. Both companies share a vision to evolve the clinical trial paradigm to speed the delivery of biopharmaceutical therapies to market. Syneos Health combines comprehensive and integrated outsourcing solutions for both clinical development and commercialization. Elligo deploys an approach that improves clinical trial access by engaging 97 percent of physicians currently not offering clinical research to their patients.  Elligo identifies patients for clinical trials using electronic health records and then provides their physicians with the infrastructure to conduct the research in their own practices. This platform enables research at practices that historically would not have had the infrastructure to conduct clinical research. Syneos Health will collaborate Elligo to pilot new ways of quickly finding patients to enlist them in clinical research.

What is Elligo’s Goes Direct approach? Traditional patient recruitment methods use conventional approaches like targeted social media and local newspaper, radio and billboard ads to advertise to patients near existing central research sites. But these tactics only engage about three percent of the population for participation in clinical research. Goes Direct approach expands access to the remaining 97 percent by using electronic health records to help physicians bring research as a care option direct to their patients. The approach leverages infrastructure, technology and expertise necessary to expand clinical research opportunities beyond central research sites.

Targeted Matching

Once the Goes Direct team have access to records they match practices to a trial or therapeutic area using EHR data. Elligo will use study criteria such as therapeutic specialty, patient pool demographics and office location to search electronic health records and connect practices with upcoming trial opportunities.

Assess Practice Interest and Study Fit

When a practice is a match for a study protocol, Elligo discusses the opportunity with them in more detail. If the practice decides to pursue the study, the Elligo study coordinator arranges the pre-study detail. If the practice decides to pursue the study, they discuss the opportunity with them in more detail. If the practice greenlights the study, the Elligo study coordinator arranges the pre-study qualification visit with the sponsor acting as coordinator on behalf of practice.

Designate Practice A Research Ready Site

Prior to study launch, Elligo provides the resources-infrastructure, technology and expertise—necessary to conduct the trial and designate the medical practice as a research read study site.

Identify Patients Using IntElligo Research Stack

Using the IntElligo platform, Elligo identifies qualified patients at the study site and encourages the physician to consider presenting the study opportunity. Patients confer with their trusted physician to decide whether to participate in the trial.

Enroll Patients Participating in the Trial

Patients interested in a study are introduced to the Elligo study coordinator and, if qualified, are asked to consent to the trial. Elligo’s study coordinator then becomes a partner in each patient’s care, taking the management burden off the physician by taking care of the details—including scheduling visits, processing paperwork, and handling data collection, regulatory compliance and sponsor communication.

Provide Trial Sponsors & CROs with Real Data from Real Patients

Elligo help trial sponsors and CROs conduct more efficient and cost-effective trials, accelerating new products to market.

In addition to the this partnership performance, TrialSite News will monitor the Elligo Goes Direct solution to assess how well it is faring in the marketplace.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.